The Effective Statistician - in association with PSI

In today's episode, Benjamin and I review 9 mistakes we often see during presentations. We'll talk about: Start with an introduction of yourself Wordy slides Monotonous Not speaking to the audience Hiding on stageReading from the slides Not creating emotions Too much content Bad ending  If you want to learn more about how to improve your presentation skills, enroll into the presentation course of The Effective Statistician: Winning with Words and Graphs: The Effective Statistician presentation and data visualization masterclass In this online, on-demand program, you will: Learn the fundamentals of preparing and delivering an engaging, impactful presentation including the five questions you need to answer for ANY presentation (and the one you should avoid)Understand the three keys to creating powerful, clear visuals and be aware of the most common mistakesHear real industry examples and experiences that demonstrate and reinforce key presentation and visualization conceptsImprove one of your own presentations (past or current) that will serve as an application of these tools and concepts Click here to learn more and enroll.

Interview with Guillaume Desachy and Nicole Krämer Biomarkers help you in all kinds of different ways, so stay tuned while Guillaume, Nicole, and I talk about the following points: What are biomarkers for you?What makes it such an interesting topic?Why do you want to revitalize the biomarker SIG?What are your goals for the SIG?The richness of biomarkers requires more advanced methods. What would you foresee your SIG to do about these?How can people join the SIG? Reference: SIGS Biomakers Interested in joining the Biomarkers SIG? Please send an email to Nicole or Guillaume. Listen to this episode and share this with your friends and colleagues!

This is a gem of an episode, jam-packed with insights and tips for everyone, including the following topics: Leading without the job title; how to influence cross-functional teamsHow he overcame the fear of public speakingHow to build and manage a virtual teamCreative thinking in an analytical disciplineBeing comfortable with not being the expert as a leaderThe power of storytelling; the stories we tell others… and ourselves!Why you need to be conscious about how you start your day Listen to this insightful episode and share this with your friends and colleagues! Here's the link to the complete episode on Jenns podcast: https://chatswithjenn.buzzsprout.com/404680/10396368-embracing-vulnerability-and-leading-with-courage-with-alex-schacht-exec-vp-of-data-science

Interview with Andrew Thomson Stay tuned while Andrew and I talk about the following: What is extrapolation?What are source and target populations?The guidance states: “Where possible, quantitative methods should be used for the collation of available data and the investigation of potential modifiers of the treatment effect”. How could such quantitative methods look like?What are the major challenges?

Interview with Gaëlle Saint-Hilary We also discuss the following points: What is dynamic borrowing?What are the impacts on sample size and effective sample size?How do we best make decisions based on the final results? Listen to this episode and share this with your friends and colleagues!

Here are some of the points we talked about: Contents of the conferenceNetworking opportunitiesSpecial interest group involvementLearning and contributing ideas Estimands sessionsMachine learningHistorical data sessionsand more.. Hoping to see you in Gothenburg! Register here: https://b-com.mci-group.com/CommunityPortal/Registration/2022PSICON.aspx?registrantID=1bf7dac5-4dd2-45de-ae1e-110901512f47 References https://www.psiweb.org/conferences/agenda https://www.psiweb.org/conferences/social-programme

Interview with Rachael Lawrance Stay tuned as we also talk about the following points: What's in the 4 guidelinesWhat factors should be considered when constructing COA-based endpoints?Effect of disease type (e.g., acute, chronic) on endpoint selection – acute symptoms resolve within weeksTreatment objective (e.g., cure, symptom management)PopulationEndpointIntercurrent Events – What can affect your measurements interpretationPopulation level summary - What Is the Final Way All Data Are Summarized and  Analyzed? References: FDA Patient focused drug development guidancePFDD Guidance 4 workshop discussion documentPublic Workshop (Dec 2019)Meeting slides Listen to this episode and share this with your friends and colleagues!

Interview with Dr. Stefan Walzer Stay tuned and listen while we talk about the following points: What are some of the risk classifications?How does the process work to get a DIGA on the list of reimbursed?What is required to get a DIGA on this list? Listen to this episode and share this with your friends and colleagues!

Interview with Antoine Regnault Stay tuned and listen while we talk about the following points: How do capitalizing on existing instruments while improving them produce good patient-reported outcomes?What is an "Item Bank"?What is the data you need to gather first before developing new instruments and items? Listen to this episode and share this with your friends and colleagues!

Interview with Jenny Devenport This is a series of episodes and today's content is the first episode. Join Jenny and I while we dive into her career and discuss important points about the following: What is Launch and LifecycleHow as it evolved in the last 2 decades with respect toPhase IV studiesObservational studiesRWEHTAGlobal vs local positionsWhat is the relationship between HTA vs non-HTA areas and collaboration with stakeholdersCollaboration with the regulatory sideInvolvement in strategic evidence generationNumber of statisticians/programmers supporting this areaOrganization within or outside of statistics departments Outsourcing approaches (strategic parts, RWE and outcomes research, studies, NMA/health economics) Listen to this episode and share this with your friends and colleagues!